Michaela Levin
CIK: 0002151012
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACRV
Acrivon Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Levin Michaela
Levin Michaela (SEC CIK 0002151012) files insider reports with the SEC as Chief Business Officer of Acrivon Therapeutics, Inc. (ACRV).
Signal8 holds 2 ownership filings by Levin Michaela (1 Form 3, 1 Form 4), filed on Sep 2, 2026. Those filings report 1 transaction, the latest on Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Levin Michaela's filings is in WATERTOWN, MA.
Recent filings by Levin Michaela
- Aug 31, 2026: Grant or award of ACRV shares (Form 4, code A).
Other insiders filing for Acrivon Therapeutics, Inc. (ACRV)
- Miller Mary, Chief Legal Officer
- Blume-Jensen Peter, President and CEO
- Peterson Katharine, Chief Accounting Officer
- Gamelin Erick, Chief Development Officer
- Devroe Eric, Chief Operating Officer
- Levy Adam D., Chief Financial Officer